AUROPHARMA Aurobindo Pharma
Healthcare
LTP
1,655
CHG · %
+14.9 (+0.91%)
VOL · TODAY
4.11L
PREV CLOSE
1,640.1
Today's range1,635.6 · 1,660.8
1,655
52-week range1,081.4 · 1,740
1,655
Loading candles…
Aurobindo Pharma is active in the development, manufacturing, and commercialization of a broad range of pharmaceutical products, including active pharmaceutical ingredients and generic medications. Operating within the pharmaceuticals, generic pharmaceuticals, and active pharmaceutical ingredients industries, the company serves markets in over 150 countries, notably the United States. It is recognized as the largest generic pharmaceutical company in the US by prescriptions dispensed and the second-largest listed Indian pharmaceutical company by revenue. Its operations include 29 commercial manufacturing facilities and 9 research and development centers. Aurobindo Pharma maintains extensive vertical integration to manage costs and enhance supply chain reliability. The company’s business segments encompass active pharmaceutical ingredients, generic pharmaceuticals, and related services.
AUROPHARMA is not part of any active scan today.
This page is a live market overview for AUROBINDO PHARMA LTD. (AUROPHARMA) on the BSE. As a listed security, AUROBINDO PHARMA LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AUROPHARMA before placing trades on tick2trade.
As of the latest feed, AUROPHARMA last traded at ₹1,655 on BSE, up ₹14.9 (0.91%) from the previous close of ₹1,640.1. Today's session range is ₹1,635.6 – ₹1,660.8, against a 52-week band of ₹1,081.4 – ₹1,740. Traded volume today stands at 4.11L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for AUROPHARMA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AUROPHARMA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for AUROBINDO PHARMA LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AUROPHARMA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AUROPHARMA option chain page linked from this overview.
// similar in healthcare326 total